C07F 9/65744
Condensed with carbocyclic or heterocyclic rings or ring systems
Official title: {condensed with carbocyclic or heterocyclic rings or ring systems}
C07F9/65744 (Condensed with carbocyclic or heterocyclic rings or ring systems) appears on 284 US grants and 243 published applications in this corpus.
Search patents in C07F- Granted patents
- 284
- Published applications
- 243
- Assignees
- 154
- Inventors
- 637
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 4 | 0 |
| 1981 | 6 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 6 | 0 |
| 1989 | 7 | 0 |
| 1990 | 5 | 0 |
| 1991 | 4 | 0 |
| 1992 | 6 | 0 |
| 1993 | 4 | 0 |
| 1994 | 5 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 10 | 0 |
| 1999 | 6 | 0 |
| 2000 | 5 | 0 |
| 2001 | 5 | 2 |
| 2002 | 5 | 7 |
| 2003 | 6 | 3 |
| 2004 | 3 | 10 |
| 2005 | 3 | 4 |
| 2006 | 3 | 9 |
| 2007 | 5 | 9 |
| 2008 | 7 | 6 |
| 2009 | 8 | 8 |
| 2010 | 9 | 11 |
| 2011 | 6 | 5 |
| 2012 | 4 | 2 |
| 2013 | 5 | 8 |
| 2014 | 9 | 17 |
| 2015 | 9 | 21 |
| 2016 | 13 | 13 |
| 2017 | 16 | 20 |
| 2018 | 16 | 10 |
| 2019 | 6 | 7 |
| 2020 | 7 | 9 |
| 2021 | 4 | 10 |
| 2022 | 9 | 15 |
| 2023 | 12 | 10 |
| 2024 | 5 | 8 |
| 2025 | 2 | 14 |
| 2026 | 5 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nucleating agent composition, olefin-based resin composition, molded article thereof, and method for producing olefin-based resin composition15 Sep 2026US 12,735,514 B2Adeka Corporation
- Cyclopentenyl purine derivative or salt thereof18 Aug 2026US 12,709,629 B2FUJIFILM Corporation
- Electrolyte additive, electrolyte for batteries including electrolyte additive, and secondary battery including electrolyte9 Jun 2026US 12,651,772 B2Soulbrain Co., Ltd.
- Prodrugs of STAT3 inhibitors5 May 2026US 12,617,810 B2Tvardi Operating Company, Inc.
- Nucleotide analogs13 Jan 2026US 12,521,397 B2The Regents of the University of California
- Electrolyte additive, electrolyte for batteries including electrolyte additive, and secondary battery including electrolyte17 Sep 2026US 2026/0279905 A1Soulbrain Co., Ltd.
- Prodrugs of stat3 inhibitors20 Aug 2026US 2026/0242402 A1Tvardi Operating Company, Inc.
- Curable phosphorus-containing compounds and preparation method therefor13 Aug 2026US 2026/0234176 A1UFC Corporation
- Method for preparing cyclic phosphate compound and derivative thereof22 Jan 2026US 2026/0022137 A1Peking University
- Delivery of therapeutic alkaloid compounds15 Jan 2026US 2026/0015322 A1Sensorium Therapeutics, Inc.
Most cited
By later US patents
- Prodrugs phosphorus-containing compounds200US 6,312,662 B1Metabasis Therapeutics, Inc. · 2001
- Dioxaphosphorinanes, their preparation and use for resolving optically active compounds126US 4,814,477 AOce-Nederland B. V. · 1989
- Transition metal complex catalyzed reactions89US 4,599,206 AUnion Carbide Corporation · 1986
- Nucleotide analogs81US 5,798,340 AGilead Sciences, Inc. · 1998
- Nucleotide analogs77US 6,225,460 B1Gilead Sciences, Inc. · 2001